Collegium Pharmaceutical, Inc (COLL): Capital Expenditures
$1.74M
Year ended 2025-12-31
$1.64M
Trailing 12 months to 2026-06-30
+2.4%
3-year compound annual growth
-20.7%
5-year compound annual growth
+17.0%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.74M | +5.3% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $1.65M | +258.4% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $461.0K | -71.6% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $1.62M | -16.6% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $1.94M | -64.9% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $5.55M | -13.9% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $6.44M | +17.5% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $5.48M | +453.2% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $990.0K | +107.5% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $477.0K | +31.8% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $362.0K | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | $8.0K | -96.1% | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | $206.0K | n/a | 2016-03-18, From 2013-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.74M | +5.3% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $211.0K | -90.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $13.80M | -39.7% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.67M | -84.0% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $15.33M | +44.2% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $34.88M | -15.0% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $1.34M | +84.6% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $310.0K | -73.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $13.84M | -14.8% |
Compare COLL, CORT, EBS, ARWR side by side · Screen every company in Pharmaceutical Preparations ↗